Novel substrate specificity and temperature-sensitive activity of Mycosphaerella graminicola CYP51 supported by the native NADPH cytochrome p450 reductase

Applied and Environmental Microbiology

Volumn 81, Issue 10, 2015, Pages 3379-3386

  Price, Claire L ^a   Warrilow, Andrew G S ^a   Parker, Josie E ^a   Mullins, Jonathan G L ^a   Nes, W David ^b   Kelly, Diane E ^a   Kelly, Steven L ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b TEXAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRICULTURE; ALCOHOLS; CHEMICAL REACTIONS; FUNGICIDES;

CYTOCHROME P450 REDUCTASE; DEMETHYLATION INHIBITORS; FUNCTIONAL ACTIVITIES; INHIBITORY CONCENTRATION; NADPH-CYTOCHROME P450 REDUCTASE; SEPTORIA LEAF BLOTCH; SUBSTRATE SPECIFICITY; TEMPERATURE SENSITIVE;

CATALYST ACTIVITY;

CYTOCHROME; ENZYME ACTIVITY; FUNGAL DISEASE; FUNGICIDE; FUNGUS; INHIBITOR; NEW RECORD; WHEAT;

EUROPE;

CANDIDA ALBICANS; FUNGI; MYCOSPHAERELLA GRAMINICOLA; SEPTORIA; TRITICUM AESTIVUM;

EBERICOL; FUNGAL PROTEIN; FUNGICIDE; LANOSTEROL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; STEROL 14ALPHA DEMETHYLASE;

AMINO ACID SEQUENCE; ANALOGS AND DERIVATIVES; ASCOMYCETES; CANDIDA ALBICANS; CHEMISTRY; ENZYME SPECIFICITY; ENZYME STABILITY; ENZYMOLOGY; GENETICS; METABOLISM; MOLECULAR GENETICS; OXIDATION REDUCTION REACTION; SEQUENCE ALIGNMENT; TEMPERATURE;

AMINO ACID SEQUENCE; ASCOMYCOTA; CANDIDA ALBICANS; ENZYME STABILITY; FUNGAL PROTEINS; FUNGICIDES, INDUSTRIAL; LANOSTEROL; MOLECULAR SEQUENCE DATA; NADPH-FERRIHEMOPROTEIN REDUCTASE; OXIDATION-REDUCTION; SEQUENCE ALIGNMENT; STEROL 14-DEMETHYLASE; SUBSTRATE SPECIFICITY; TEMPERATURE;

EID: 84930013890     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.03965-14     Document Type: Article

References (32)

1. Hardwick NV, Jones DR, Slough JE. 2001. Factors affecting diseases of winter wheat in England and Wales, 1989-98 Plant Pathol 50:650-652. http://dx.doi.org/10.1046/j.1365-3059.2001.00641.x.
2. Dean R, Van Kan JAL, Pretorius ZA, Hammond-Kosack KE, Di Pietro A, Spanu PD, Rudd JJ, Dickman M, Kahmann R, Ellis J, Foster GD. 2012. The top 10 fungal pathogens in molecular plant pathology Mol Plant Pathol 13:414-430. http://dx.doi.org/10.1111/j.1364-3703.2011.00783.x.
3. Nes WR, McKean MR. 1977. Biochemistry of steroids and other isopentenoids. University Park Press, Baltimore, MD.
4. Schaller H. 2003. The role of sterols in plant growth and development Prog Lipid Res 42:163-175. http://dx.doi.org/10.1016/S0163-7827(02)00047-4.
5. Leroux P, Walker AS. 2011. Multiple mechanisms account for resistance to sterol 14_-demethylation inhibitors in field isolates of Mycosphaerella graminicola Pest Manage Sci 67:44-59. http://dx.doi.org/10.1002/ps.2028.
6. Cools HJ, Fraaije BA. 2013. Update on mechanisms of azole resistance in Mycosphaerella graminicola and implications for future control Pest Manage Sc 69:150-155. http://dx.doi.org/10.1002/ps.3348.
7. Morio F, Loge C, Besse B, Hennequin C, Le Pape P. 2010. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azolesusceptible and azole-resistant clinical isolates: new substitutions and a review of the literature Diagn Microbiol Infect Dis 66:373-384. http://dx .doi.org/10.1016/j.diagmicrobio.2009.11.006.
8. Becher R, Wirsel SG. 2012. Fungal cytochrome P450 sterol 14_- demethylase (CYP51) and azole resistance in plant and human pathogens Appl Microbiol Biotechnol 95:825- 840. http://dx.doi.org/10.1007/s00253-012-4195-9.
9. Murataliev MB, Feyereisen R, Walker FA. 2004. Electron transfer by diflavin reductases Biochim Biophys Acta 1698:1-26. http://dx.doi.org /10.1016/j.bbapap.2003.10.003.
10. Barnes HJ, Arlotto MP, Waterman MR. 1991. Expression and enzymatic activity of recombinant cytochrome P450 17_-hydroxylase in Escherichia coli Proc Natl Acad Sci U S A 88:5597-5601. http://dx.doi.org/10.1073/pnas.88.13.5597.
11. Arase M, Waterman MR, Kagawa N. 2006. Purification and characterization of bovine steroid 21-hydroxylase (P450c21) efficiently expressed in Escherichia coli Biochem Biophys Res Commun 344:400-405. http://dx.doi.org/10.1016/j.bbrc.2006.03.067.
12. Vermilion JL, Coon MJ. 1978. Purified liver microsomal NADPHcytchrome P450 reductase J Biol Chem 253:2694-2704.
13. Black SD, Coon MJ. 1982. Structural features of liver microsomal NADPH-cytochrome P-450 reductase- hydrophobic domain, hydrophilic domain and connecting region J Biol Chem 257:5929-5938.
14. Lepesheva GI, Ott RD, Hargrove TY, Kleshchenko YY, Schuster I, Nes WD, Hill GC, Villalta F, Waterman MR. 2007. Sterol 14_-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth Chem Biol 14:1283-1293. http://dx.doi.org/10.1016/j.chembiol.2007.10.011.
15. Warrilow AGS, Martel CM, Parker JE, Melo N, Lamb DC, Nes D, Kelly DE, Kelly SL. 2010. Azole binding properties of Candida albicans sterol 14-_ demethylase (CaCYP51) Antimicrob Agents Chemother 54:4235-4245. http://dx.doi.org/10.1128/AAC.00587-10.
16. Parker JE, Warrilow AGS, Cools HJ, Martel CM, Nes WD, Fraaije BA, Lucas JA, Kelly DE, Kelly SL. 2011. Mechanism of binding of prothioconazole to Mycosphaerella graminicola CYP51 differs from that of other azole antifungals Appl Environ Microbiol 77:1460-1465. http://dx.doi .org/10.1128/AEM.01332-10.
17. Parker JE, Warrilow AG, Cools HJ, Fraaije BA, Lucas JA, Rigdova K, Griffiths WJ, Kelly DE, Kelly SL. 2013. Prothioconazole and prothioconazole- desthio activities against Candida albicans sterol 14-_- demethylase Appl Environ Microbiol 79:1639-1945. http://dx.doi.org/10.1128/AEM.03246-12.
18. Mullins JGL, Parker JE, Cools HJ, Togawa RC, Lucas JA, Fraaije BA, Kelly DE, Kelly SL. 2011. Molecular modelling of the emergence of azole resistance in Mycosphaerella graminicola PLoS One 6:e20973. http://dx .doi.org/10.1371/journal.pone.0020973.
19. Monk BC, Tomasiak TM, Keniya MV, Huschmann FU, Tyndall JD, O'Connell JD, III, Cannon RD, McDonald JG, Rodriguez A, Finer-Moore JS, Stroud RM. 2014. Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer Proc Natl Acad Sci U S A 111:3865-3870. http://dx .doi.org/10.1073/pnas.1324245111.
20. Park HG, Lim YR, Eun CY, Han S, Han JS, Cho KS, Chun YJ, Kim D. 2010. Candida albicans NADPH-P450 reductase: expression, purification and characterization of recombinant protein Biochem Biophys Res Commun 396:534-538. http://dx.doi.org/10.1016/j.bbrc.2010.04.138.
21. Oprian DD, Coon MJ. 1982. Oxidation-reduction states of FMN and FAD in NADPH-cytochrome P-450 reductase during reduction by NADPH J Biol Chem 257:8935-8944.
22. Kurzban GO, Howarth J, Plamer G, Strobel HW. 1990. NADPHcytochrome P-450 reductase: physical properties and redox behavior in the absence of the FAD moiety J Biol Chem 265:12272-12279.
23. Warrilow AGS, Lamb DC, Kelly DE, Kelly SL. 2002. Phanerochaete chrysosporium NADPH-cytochrome P450 reductase kinetic mechanism Biochem Biophys Res Commun 299:189-1915. http://dx.doi.org/10.1016/S0006-291X(02)02600-1.
24. Lamb DC, Warrilow AGS, Venkateswarlu K, Kelly DE, Kelly SL. 2001. Activities and kinetic mechanism of native and soluble NADPHcytochrome P450 reductase Biochem Biophys Res Commun 286:48-54. http://dx.doi.org/10.1006/bbrc.2001.5338.
25. Groves JT. 2005. Models and mechanism of cytochrome P450 action, p 1- 43. In Ortiz de Montellano PR (ed), Cytochrome P450: structure, mechanism, and biochemistry, 3rd ed. Kluwer Academic/Plenum Publishers, New York, NY.
26. Hayashi S, Omata Y, Sakamoto H, Hara T, Noguchi M. 2003. Purification and characterization of a soluble form of rat liver NADPHcytochrome P-450 reductase highly expressed in Escherichia coli Protein Expr Purif 29:1-7. http://dx.doi.org/10.1016/S1046-5928(03)00023-8.
27. Marohnic CC, Panda SP, Martasek P, Masters BS. 2006. Diminished FADbinding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase J Biol Chem 281:35975-35982. http://dx.doi.org/10.1074/jbc.M607095200.
28. Lamb DC, Kelly DE, Kelly SL. 1998. Molecular diversity of sterol 14_- demethylase substrates in plants, fungi and humans FEBS Lett 425:263-265. http://dx.doi.org/10.1016/S0014-5793(98)00247-6.
29. Lepesheva GI, Villalta F, Waterman MR. 2011. Targeting Trypanosoma cruzi sterol 14_-demethylase (CYP51) Adv Parasitol 75:65-87. http://dx .doi.org/10.1016/B978-0-12-385863-4.00004-6.
30. Ekins S, Mankowski DC, Hoover DJ, Lawton MP, Treadway JL, Harwood HJ. 2007. Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors Drug Metab Dispos 35:493-500. http://dx.doi.org/10.1124/dmd.106.013888.
31. Trösken ER, Adamska M, Arand M, Zarn JA, Patten C, Völkel W, Lutz WK. 2006. Comparison of lanosterol-14_-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles Toxicology 228:24-32. http://dx.doi.org/10.1016/j.tox.2006.08.007.
32. Kitahama Y, Nakamura M, Yoshida Y, Aoyama Y. 2009. The construction and characterization of self-sufficient lanosterol 14-demethylase fusion proteins consisting of yeast CYP51 and its reductase Biol Pharm Bull 32:558-563. http://dx.doi.org/10.1248/bpb.32.558.